)
)
Ironwood Pharmaceuticals Investor Relations Material
Latest events
Q4 2024
Ironwood Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Ironwood Pharmaceuticals Inc
Access all reports
Ironwood Pharmaceuticals, Inc., is a healthcare company that focuses on the development and commercialization of gastrointestinal products. The company develops linaclotide, a guanylate cyclase type-C agonist for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation under the LINZESS name in the United States and under the CONSTELLA name in Europe; and lesinurad for gout.
Key slides for Ironwood Pharmaceuticals Inc
Q3 2024
Ironwood Pharmaceuticals Inc
Q1 2024
Ironwood Pharmaceuticals Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
IRWD
Country
🇺🇸 United States